, Singapore

Here are 3 deterrents to RMG's medical tourism growth

For starters, it is still seeing a drop in medical tourism.

For the analysts at CIMB, it is too premature to start turning positive on Raffles Medical Group, seeing that the 1.3% full-year growth is not something to spark a turnaround.

According to CIMB, the group's 4Q16 top line growth was weak amidst slowing demand. In the said quarter, Raffles incurred a 1% QoQ sales decline.

Quoting the group, CIMB said that this is attributed to the weakness to medical tourism.

"The miss in medical tourism mostly came from Indonesian patients. Indo patients now form less than 20% of RFMD’s total foreign patients (prev. 20+%). Even as management cited growth from other markets including Malaysia, Vietnam, Myanmar and China, the tone was that medical tourism growth will likely be subdued," CIMB said.

CIMB stated three deterrents to Raffles' medical tourism growth including a strong dollar, the rising private healthcare costs, and the strong competition from regional peers.

"Weak medical tourism, limited domestic growth and expansion costs are hitting the group’s hospital segment. The hospital saw its first ever PBT decline in FY16 at 3% YoY," CIMB noted. 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

Asia insurers risk irrelevance as protection gaps widen
An expert said Singapore saves 36% of its income despite having high protection and critical illness gaps.
Insurance
Banks urged to turn pricing into a strategic growth lever
A consultant says data-driven pricing can boost revenue and lower funding costs without sacrificing volume.
AI governance failures threaten banks’ returns
95% of GenAI spend has no outcome as organisations remain in the early stages of adoption.